tirzepatide mash phase 3 🔴 #SYNERGY_NASH Trial (NEJM, 2024) for Metabolic Dysfunction-Associated Steatohepatitis with Liver Fibrosis 👉 In this 2 trial involving participants with and moderate or severe fibrosis, treatment with tirzepatide for Tirzepatide in Metabolically Dysfunctional‐Associated Steatohepatitis
Pay in 4 interest-free payments of $6.71 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
























